Correlation Between Orphazyme and ChemoMetec
Can any of the company-specific risk be diversified away by investing in both Orphazyme and ChemoMetec at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orphazyme and ChemoMetec into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orphazyme AS and ChemoMetec AS, you can compare the effects of market volatilities on Orphazyme and ChemoMetec and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orphazyme with a short position of ChemoMetec. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orphazyme and ChemoMetec.
Diversification Opportunities for Orphazyme and ChemoMetec
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Orphazyme and ChemoMetec is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Orphazyme AS and ChemoMetec AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ChemoMetec AS and Orphazyme is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orphazyme AS are associated (or correlated) with ChemoMetec. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ChemoMetec AS has no effect on the direction of Orphazyme i.e., Orphazyme and ChemoMetec go up and down completely randomly.
Pair Corralation between Orphazyme and ChemoMetec
Assuming the 90 days trading horizon Orphazyme AS is expected to generate 0.66 times more return on investment than ChemoMetec. However, Orphazyme AS is 1.52 times less risky than ChemoMetec. It trades about -0.13 of its potential returns per unit of risk. ChemoMetec AS is currently generating about -0.35 per unit of risk. If you would invest 118,980 in Orphazyme AS on January 26, 2024 and sell it today you would lose (11,500) from holding Orphazyme AS or give up 9.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 95.0% |
Values | Daily Returns |
Orphazyme AS vs. ChemoMetec AS
Performance |
Timeline |
Orphazyme AS |
ChemoMetec AS |
Orphazyme and ChemoMetec Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Orphazyme and ChemoMetec
The main advantage of trading using opposite Orphazyme and ChemoMetec positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orphazyme position performs unexpectedly, ChemoMetec can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChemoMetec will offset losses from the drop in ChemoMetec's long position.Orphazyme vs. Zealand Pharma AS | Orphazyme vs. Ambu AS | Orphazyme vs. BioPorto | Orphazyme vs. Bavarian Nordic |
ChemoMetec vs. cBrain AS | ChemoMetec vs. Ambu AS | ChemoMetec vs. Genmab AS | ChemoMetec vs. Zealand Pharma AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |